Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.48	35.67	46.67	106.75	86.86
Short-Term Investments	-	-	-	9.63	-
Cash & Short-Term Investments	15.48	35.67	46.67	116.37	86.86
Cash Growth	-56.59%	-23.58%	-59.89%	33.97%	-31.85%
Other Current Assets	7.39	3.66	5.86	9.49	18.13
Total Current Assets	22.87	39.33	52.53	125.86	104.99
Net Property, Plant & Equipment	1.18	1.54	1.77	1.85	1.1
Goodwill	-	-	-	-	32.97
Other Long-Term Assets	-	-	-	0.04	0.04
Total Assets	24.05	40.87	54.3	127.75	139.1
Accounts Payable	10.14	7.85	5.1	4.28	3.75
Accrued Expenses	18.65	12.91	18.66	7.99	7.07
Other Current Liabilities	1.84	1.42	0.97	0.81	0.59
Total Current Liabilities	30.62	22.18	24.73	13.08	11.4
Long-Term Leases	0.11	0.26	0.64	0.99	0.58
Total Long-Term Liabilities	0.11	0.26	0.64	0.99	0.58
Total Liabilities	30.73	22.44	25.37	14.07	11.99
Preferred Stock	-	0.01	-	-	-
Common Stock	-	0.01	0	0	0
Additional Paid-in Capital	599.24	525.61	436.06	427.93	324.24
Accumulated Other Comprehensive Income	2.65	4.21	3.76	3.04	-0.25
Retained Earnings	-608.57	-511.4	-410.89	-317.28	-196.87
Shareholders' Equity	-6.68	18.44	28.93	113.68	127.12
Total Liabilities & Equity	24.05	40.87	54.3	127.75	139.1
Total Debt	0.11	0.26	0.64	0.99	0.58
Net Cash (Debt)	15.38	35.4	46.04	115.38	86.28
Net Cash Growth	-56.57%	-23.09%	-60.10%	33.73%	-31.94%
Net Cash Per Share	0.10	0.35	1.04	3.63	3.65
Book Value	-6.68	18.44	28.93	113.68	127.12
Book Value Per Share	-0.04	0.18	0.65	3.57	5.37
Tangible Book Value	-6.68	18.44	28.93	113.68	94.15
Tangible Book Value Per Share	-0.04	0.18	0.65	3.57	3.98

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q